Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vigantol oil add-on therapy in relapsing-remitting multiple sclerosis
2010-020328-23Phase 2Completed
- Sponsor
- Merck Serono
- Start
- Aug 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of vitamin d in multiple sclerosis (MS) (3 arms), sponsored by Merck Serono. Primary endpoint: Disease activity-free status at week 48. Started Aug 2010; status: completed.
02
Drugs
vitamin d
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2010-020328-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020328-23.